Interim Financial Statements
for the 6-month period ended 30 June 2018Find out more
Malin (ISE:MLC) is a company investing in high-growth opportunities in the global healthcare sector. Its purpose is to create shareholder value through the application of long-term capital and operational and strategic expertise to a diverse range of global healthcare businesses.
Malin has a focus on innovative businesses underpinned by exceptional science, with a proven, sustainable business model. Formed in 2015, Malin works with its diverse portfolio of investee companies, providing strategic and financial support to enable them to reach their value potential. Malin, with a strong leadership team and Board, is headquartered and domiciled in Ireland and listed on Euronext Dublin, with offices in London and a global investment focus.
September 21, 2018Melinta Therapeutics Receives Positive CHMP Opinion for Vabomere™ (meropenem and vaborbactam)
September 18, 2018Melinta Therapeutics Names Peter Milligan as Chief Financial Officer